Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer
Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer
Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer
Submitted by
admin
on January 3, 2018 - 10:06am
Source:
Marketwatch
News Tags:
Sangamo
Pfizer
ALS
gene therapy
drug development
Headline:
Sangamo shares surge 3.4% on $12 mln ALS gene therapy collaboration with Pfizer
Do Not Allow Advertisers to Use My Personal information
